Thus, the expression of the components of the Shh signaling pathway, including GLI1, GLI2, GLI3, PTCH, and SMO, was found to be common in various tumors of the nervous system, including gliomas [1, 36], and correlated with a poor prognosis of patient survival [37]. This evidence concerns the gene GLI3 and central nervous system cancer.